Viewing StudyNCT04127110



Ignite Creation Date: 2024-05-06 @ 1:46 PM
Last Modification Date: 2024-10-26 @ 1:20 PM
Study NCT ID: NCT04127110
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-16
First Post: 2019-10-14

Brief Title: Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization: European Organisation for Research and Treatment of Cancer - EORTC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-11-17
Start Date Type: ACTUAL
Primary Completion Date: 2024-07
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-11
Completion Date Type: ESTIMATED
First Submit Date: 2019-10-14
First Submit QC Date: October 14 2019
Study First Post Date: 2019-10-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-15
Last Update Post Date: 2024-02-16
Last Update Post Date Type: ACTUAL